GHRS today

$19.10+$0.61 (+3.30%)close Nov 13, 2026

Trend

DailyUptrend (starting)

4 hourStrong Bearish

1 hourExpanding

15 minStrong Bearish

5 minStrong Bullish

Daily trend turns down below $17.54

Key levels

Resistance$22.13

Resistance$19.85

Support$18.13

Support$16.45

About GH Research

GH Research is a clinical-stage biopharmaceutical company developing mebufotenin-based therapies for psychiatric and neurological disorders. Its lead candidate, GH001, is an inhalable mebufotenin product, while GH002 is an intravenous formulation. The company's initial focus is treatment-resistant depression, with additional research in bipolar II disorder and postpartum depression. It operates in Ireland and the United Kingdom and is conducting clinical trials in Europe.

Based on the company's 20-F filed Mar 5, 2026.

Nasdaq · Healthcare

GH Research PLC (GHRS)

$19.36+0.87 (+4.71%)

WATCHLISTGrade: B+Risk: LOW

1D 5D1M1Y 5Y MaxSign up for all timeframes

High19.79

Low18.00

Open18.84

Volume340K

Avg Vol301K

VWAP19.34

30d High22.17

30d Low18.07

30d Chg-12.67%

See full chart with real-time data

What Is the Price Target for GHRS?

SEPT Low Target

$39.00

SEPT Mid Target

$40.00

SEPT High Target

$65.00

Analyst Consensus

$40.00

Current: $18.73Upside: +113.6%Confidence: 85%Method: Analyst Consensus

Is GHRS a Buy or Sell Right Now?

Investability Score

WATCHLIST12-18 months

News summary · last 30 days

Nov 13▲ UpEarningsLeadership4 articles

GH Research reported a Q3 2026 quarterly loss of $0.18 per share, narrower than the $0.32 loss analysts had projected, a result that came in ahead of consensus estimates. The stock closed at $19.10, up 1.38% on the day, trading between a low of $18.00 and a high of $19.81 on volume of 555,287. The company also announced the appointment of Dr. Vanina Popova as Chief Development Officer, who will lead development of GH001. The better-than-expected earnings result is the primary bullish signal, while the leadership change carries neutral sentiment and low impact.

Critical news

Nov 13HIGHEarnings: growth/beat

Thesis

AI-Powered Trading Signals

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for GHRS.

Start Free Trial →

Is GHRS Overvalued or Undervalued?

Valuation Verdict

UNDERVALUED

Methods Used

Analyst Consensus

Fair Value

$40.00

Moat Score

NONE

4/9

Piotroski Score

82.4

Altman Z-Score

What Is Smart Money Doing with GHRS?

Insider Signal

NEUTRAL

0 buys / 0 sells (90d)

Congress Signal

NEUTRAL

0 buys / 0 sells (90d)

Institutional

N/A

Short Squeeze Risk

HIGH

Signal: HIGH_SHORT_INTEREST

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See All Smart Money Signals →

GHRS Growth Story

Revenue YoY

N/A%

3yr Revenue CAGR

N/A%

EPS Growth YoY

-5.33%

FCF Growth YoY

-3.2%

Revenue Trend

UNKNOWN

Dark Pool Trades for GHRS

PREVIEW

SEPT Investing tracks real-time dark pool institutional trades for GHRS, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.

Time	Price	Size	Value	Side
16:07:33	$19.61	1,095	$$21K	MIDPOINT
15:43:12	$19.45	25,000	$$486K	SELL
15:29:30	$19.43	150,000	$$2.9M	SELL
15:22:54	$19.40	3,860	$$75K	BUY
15:20:45	$19.43	50,000	$$972K	SELL

5 dark pool trades shown · $$4.5M preview volume

Real-time institutional flow, block trades, and net positioning

See all dark pool activity

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for GH Research PLC (GHRS) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (0 articles analyzed), and SEC filing intelligence...

AI-Powered Trading Signals.

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.

Try SEPT Free for 7 Days →

GHRS — frequently asked questions

What is GHRS stock price today?

GH Research PLC (GHRS) is at $19.10, up 3.30% (+$0.61) at the Nov 13, 2026 close.

Why is GHRS stock up today?

Nov 13, 2026: GH Research reported a Q3 2026 quarterly loss of $0.18 per share, narrower than the $0.32 loss analysts had projected, a result that came in ahead of consensus estimates. The stock closed at $19.10, up 1.38% on the day, trading between a low of $18.00 and a high of $19.81 on volume of 555,287.

What is the GHRS price target?

The average analyst price target for GHRS is $40.00, ranging from $39 to $65, based on 6 analysts. Latest: Cantor Fitzgerald maintains on Aug 7, 2026.

What do analysts rate GHRS?

Analyst ratings for GHRS: 0 Buy, 7 Hold, 0 Sell — consensus Hold.

Did GHRS beat earnings?

GHRS last reported on Aug 6, 2026: EPS -$0.23 vs -$0.29 expected — a beat of 19.6%.

How much debt does GHRS have?

GH Research PLC reported $0M of debt and $246M of cash (Dec 31, 2025).

What are GHRS support and resistance levels?

Support: $18.13, $16.45, $14.33. Resistance: $19.85, $22.13, $25.00.

What are insiders doing with GHRS?

Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.

What is the latest news on GHRS?

Nov 13, 2026: GH Research Posts Smaller Q3 Loss Than Analysts Expected · Nov 13, 2026: GH Research names Vanina Popova Chief Development Officer